Financial results - CORADAMED SRL

Financial Summary - Coradamed Srl
Unique identification code: 28150768
Registration number: J08/366/2011
Nace: 8622
Sales - Ron
153.310
Net Profit - Ron
106.463
Employee
2
The most important financial indicators for the company Coradamed Srl - Unique Identification Number 28150768: sales in 2023 was 153.310 euro, registering a net profit of 106.463 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Coradamed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 36.460 60.178 74.357 74.189 75.236 75.799 76.274 91.640 117.977 153.310
Total Income - EUR 36.476 60.201 74.373 74.189 75.298 75.958 76.290 91.674 121.169 153.488
Total Expenses - EUR 9.929 20.514 22.862 34.860 27.949 31.900 28.222 30.719 34.445 45.522
Gross Profit/Loss - EUR 26.546 39.687 51.510 39.329 47.349 44.059 48.068 60.955 86.723 107.966
Net Profit/Loss - EUR 25.452 37.881 50.023 38.587 46.597 43.301 47.359 60.057 85.537 106.463
Employees 0 1 1 1 1 1 1 1 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 30.3%, from 117.977 euro in the year 2022, to 153.310 euro in 2023. The Net Profit increased by 21.185 euro, from 85.537 euro in 2022, to 106.463 in the last year.

Check the financial reports for the company - Coradamed Srl

Rating financiar

Financial Rating -
Coradamed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Coradamed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Coradamed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Coradamed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Coradamed Srl - CUI 28150768

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 9.645 6.785 18.097 11.281 40.842 27.570 16.030 6.720 29.051 22.328
Current Assets 26.326 49.227 38.132 46.999 35.265 46.955 56.869 73.216 62.867 85.962
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 3.250 8.854 10.567 4.455 6.952 5.371 580 27.328 44.731 77.728
Cash 23.076 40.373 27.565 42.543 28.314 41.584 56.289 45.888 18.136 8.233
Shareholders Funds 35.030 55.206 50.076 38.639 46.648 52.168 56.058 68.563 85.586 106.512
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 940 806 6.152 19.640 29.460 22.357 16.840 11.373 6.332 1.777
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 85.962 euro in 2023 which includes Inventories of 0 euro, Receivables of 77.728 euro and cash availability of 8.233 euro.
The company's Equity was valued at 106.512 euro, while total Liabilities amounted to 1.777 euro. Equity increased by 21.185 euro, from 85.586 euro in 2022, to 106.512 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Coradamed Srl

Comments - Coradamed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.